SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-016004
Filing Date
2024-05-10
Accepted
2024-05-10 16:07:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A aytu20240508c_defa14a.htm DEFA14A 8172
2 nanda_page1.jpg GRAPHIC 241370
3 nanda_page2.jpg GRAPHIC 147337
  Complete submission text file 0001437749-24-016004.txt   544768
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-38247 | Film No.: 24934867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)